Skip to content
Review Open access

Engineered bacterial therapeutics from synthetic biology to clinical translation: A multi-database scientometric analysis, 2000–2026

Aug 2026 · Human Vaccines & Immunotherapeutics · Vol 22 · 0 citations · 93 references
Medicine

TL;DR

A multi-database bibliometric analysis to map the knowledge structure, collaboration patterns, and translational direction of engineered bacterial therapeutics showed a shift from bacterial chassis construction and circuit design toward engineered probiotics, gut microbiota-related therapy, cancer immunotherapy, drug delivery, live biotherapeutic products, and clinical translation.

Abstract

ABSTRACT Engineered bacterial therapeutics integrate programmable strain engineering with biomedical functions such as sensing, delivery, immune modulation, microbiome intervention, and disease management. This study conducted a multi-database bibliometric analysis to map the knowledge structure, collaboration patterns, and translational direction of this field. Bibliographic records were retrieved from Web of Science Core Collection, Scopus, and PubMed for publications from 1 January 2000 to 1 June 2026. After document-type filtering, time restriction, deduplication, language screening, and manual eligibility assessment, 1,730 English-language articles and reviews were included. CiteSpace 6.4.R1, VOSviewer 1.6.20, and the bibliometrix R package were used to analyze publication trends, collaboration networks, journal co-citation, dual-map citation trajectories, citation bursts, keyword co-occurrence, and thematic evolution. Publication output increased steadily, with faster growth after 2020; 2025 was the highest-output complete year, while 2026 represented a partial retrieval year. China and the United States were the leading contributors, although institutional collaboration remained regionally clustered. Co-citation, citation-burst, and keyword analyses showed a shift from bacterial chassis construction and circuit design toward engineered probiotics, gut microbiota-related therapy, cancer immunotherapy, drug delivery, live biotherapeutic products, and clinical translation. Persistent translational priorities include controllability, safety, manufacturing consistency, and regulatory alignment.

Read PDF

Similar papers

Open access Sep 2026

Engineered bacteria and engineered probiotics for intestinal disease therapy: a bibliometric and knowledge mapping analysis

The bibliometric evidence indicates that recent research attention is increasingly focused on programmable living therapeutic strategies, rather than therapeutic performance directly established by the bibliometric data.

Wei Sun, Hong-Rui Liu, An-Qi Shao et al. · 0 citations
Review Open access Sep 2026

Global research trends and emerging frontiers of gut microbiota–drug interactions: a bibliometric and visualization analysis (2003–2025)

Background The gut microbiota can alter drug metabolism, efficacy, and toxicity, while medications can reciprocally reshape microbial communities. However, the structure and maturation of research specifically addressing these bidirectional interactions have not been comprehensively mapped. Methods The Web of Science C...

Ying-Xian Dong, Long-Xi He, H. Du · 0 citations
Open access Jan 2026

Knowledge Mapping of Human Genetic Variation in Multiomics Biomarker Translation: A Bibliometric Analysis

Human genetic variation and multiomics biomarker translation has emerged as a rapidly developing research field at the intersection of molecular medicine, bioinformatics, and clinical decision‐making. This study used bibliometric methods to map its global structure, intellectual base, and thematic evolution. The eligib...

Bang-Shu Zhao, Wei Ran, Ning Liang · 0 citations
Review Open access Sep 2026

Nanomedicine and the tumor immune microenvironment in cancer immunotherapy: a bibliometric and knowledge-mapping analysis

This study clarifies the intellectual structure and evolution of nano-immuno-oncology and identifies three major themes: photodynamic therapy combined with immune checkpoint blockade; tumor-microenvironment remodeling and melanoma immunotherapy; and nanomaterial-mediated immune activation involving cell death, antigen...

Yan-Zhen Mai, Ya-Qin Wang, Wei-Wei Li et al. · 1 citation
Review Sep 2026

Mapping immune cell metabolic reprogramming from mechanistic hotspots to translational directions: A bibliometric analysis with exploratory clinical evidence.

This study quantitatively and visually evaluated the overall development of immune cell metabolic reprogramming research and suggested that the field is moving from single pathway descriptions toward a research model that integrates immune cell stratification, disease context stratification, and context specific transl...

Lin-Xi Liu, Si-Xian Chen, Hao-Yu Wan · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.